ABBV
Abbvie Inc
Price:  
265.12 
USD
Volume:  
3,431,949.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Abbvie Relative Valuation

-56.7%
Upside

As of 2026-09-25, the Relative Valuation of Abbvie Inc (ABBV) is 114.77 USD. This relative valuation is based on P/E multiples. With the latest stock price at 265.12 USD, the upside of Abbvie Inc based on Relative Valuation is -56.7%.

The range of the Relative Valuation is 95.13 - 170.64 USD.

Range Selected
Trailing P/E multiples 30.4x - 47.8x 35.4x
Forward P/E multiples 24.4x - 29.2x 26.4x
Fair Price 95.13 - 170.64 114.77
Upside -64.1% - -35.6% -56.7%
265.12 USD
Stock Price
114.77 USD
Fair Price

Abbvie Relative Valuation - Historical P/E Data

Date P/E
2026-09-24 74.23
2026-09-23 74.22
2026-09-22 74.26
2026-09-21 74.05
2026-09-18 73.91
2026-09-17 73.93
2026-09-16 73.50
2026-09-15 73.65
2026-09-14 73.30
2026-09-11 71.99
2026-09-10 71.40
2026-09-09 70.25
2026-09-08 69.66
2026-09-04 71.81
2026-09-03 72.86
2026-09-02 73.28
2026-09-01 72.80
2026-08-31 71.80
2026-08-28 71.53
2026-08-27 72.28
2026-08-26 73.61
2026-08-25 74.42
2026-08-24 74.07
2026-08-21 74.19
2026-08-20 73.31
2026-08-19 74.47
2026-08-18 72.50
2026-08-17 70.09
2026-08-14 69.85
2026-08-13 70.23
2026-08-12 69.65
2026-08-11 70.02
2026-08-10 69.43
2026-08-07 68.89
2026-08-06 68.28
2026-08-05 68.94
2026-08-04 68.26
2026-08-03 68.63
2026-07-31 70.26
2026-07-30 72.07
2026-07-29 73.72
2026-07-28 73.70
2026-07-27 71.93
2026-07-24 72.62
2026-07-23 71.94
2026-07-22 70.92
2026-07-21 71.71
2026-07-20 70.95
2026-07-17 71.26
2026-07-16 71.23